MedMesh.i
Curation
PubMed
Racine
Curation
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Catechol O-Methyltransferase Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Catechol O-Methyltransferase < Catechol O-Methyltransferase Inhibitors < Catecholamines  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000951 (2011) O. Rascol [France]Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
000970 (2011) Jean-Christophe Corvol [France] ; Cécilia Bonnet ; Fanny Charbonnier-Beaupel ; Anne-Marie Bonnet ; Marie-Hélène Fiévet ; Agnès Bellanger ; Emmanuel Roze ; Gayané Meliksetyan ; Mouna Ben Djebara ; Andreas Hartmann ; Lucette Lacomblez ; Cédric Vrignaud ; Noël Zahr ; Yves Agid ; Jean Costentin ; Jean-Sébastien Hulot ; Marie VidailhetThe COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
000E78 (2005) Frédéric Libert [France] ; François Coudoré ; Damien Richard ; Franck Durif ; Alain EschalierDevelopment of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine.
000F19 (????) O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; W. Poewe ; F. Stocchi ; E. TolosaRasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
001229 (2001) F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. BourdeixEfficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study.
001586 (1995) P. Limousin [France] ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E PerretAcute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Catechol O-Methyltransferase Inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Catechol O-Methyltransferase Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Catechol O-Methyltransferase Inhibitors
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024